Additionally, we will further explore the potential of FAK FAT PPI inhibitors in other indications, including idiopathic pulmonary fibrosis, which has been shown to be negatively regulated by Ad-FRNK9. This evidence concerns the gene PTK2 and pulmonary fibrosis.